On this episode of Stock Movers:
- AstraZeneca shares rise as much as 2% after the drugmaker reported revenue for the second quarter that were ahead of market expectations. JPMorgan analysts called it a “high quality” sales beat. 
- Philips increased its profitability outlook as the impact of the trade war was not as severe as it feared. The company now expects full-year adjusted operating earnings margin of as much as 11.8%, a 50 basis points increase from the previous outlook, according to a statement.
- Stellantis shares fall as much as 3.4% after the carmaker updated its estimate of 2025 net tariff impact to about €1.5 billion, of which €300 million was incurred in 1H25.

On this episode of Stock Movers: - AstraZeneca shares rise as much as 2% after the drugmaker reported revenue for the second quarter that were ahead of market expectations. JPMorgan analysts called it a &ldquo;high quality&rdquo; sales beat. - Philips increased its profitability outlook as the impact of the trade war was not as severe as it feared. The company now expects full-year adjusted operating earnings margin of as much as 11.8%, a 50 basis points increase from the previous outlook, according to a statement. - Stellantis shares fall as much as 3.4% after the carmaker updated its estimate of 2025 net tariff impact to about &euro;1.5 billion, of which &euro;300 million was incurred in 1H25.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

AstraZeneca Climbs, Philips Soars, Stellantis Falls 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9632b35c-57ec-444a-97b6-b3290084f442/transcript

Advertisement